Sanofi, Boehringer Ingelheim consumer-healthcare deal approved in Brazil
MLex Summary: French drugmaker Sanofi has obtained antitrust clearance in Brazil to buy Boehringer Ingelheim’s consumer-healthcare business. The transaction is part of an asset swap in which Boehringer will trade its...To view the full article, register now.
Already a subscriber? Click here to view full article